EV/EBITDA
-99.80
-1.10-1.11%
10 min ago
Summary
- As of February 25, 2025, BCRX EV/EBITDA is -99.80, with a fall of -1.10 (-1.11%) during the most recent trading day.
- Over the past year, BCRX EV/EBITDA has dropped by -83.29 (-504.48%).
- BCRX EV/EBITDA is now -15941.27% below its all-time high of 0.63.
Performance
BCRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
BCRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.1% | +1.1% | +1.6% |
| 1 m1 month | -6.1% | +6.1% | +8.9% |
| 3 m3 months | -9.7% | +9.7% | +14.3% |
| 6 m6 months | -83.3% | +2.1% | +4.8% |
| ytdytd | -7.4% | +7.4% | +10.8% |
| 1 y1 year | -504.5% | +26.9% | +42.4% |
| 5 y5 years | -2897.0% | +660.6% | +267.0% |
BCRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -6.5% | -109.38 | +8.8% | |
| 3 m | 3-month | -89.28 | -11.8% | -109.38 | +8.8% |
| 6 m | 6-month | -52.23 | -91.1% | -109.38 | +8.8% |
| 1 y | 1-year | -14.91 | -569.4% | -109.38 | +8.8% |
| 3 y | 3-year | -13.44 | -642.6% | -109.38 | +8.8% |
| 5 y | 5-year | -2.26 | -4315.9% | -109.38 | +8.8% |
| alltime | all time | 0.63 | <-9999.0% | -248.59 | +59.9% |
BioCryst Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -99.80(+7.4%) |
| 2024 | -92.93(+454.8%) |
| 2023 | -16.75(-6.1%) |
| 2022 | -17.84(-17.8%) |
| 2021 | -21.70(+174.0%) |
| 2020 | -7.92(+52.0%) |
| 2019 | -5.21(-48.5%) |
| 2018 | -10.11(+17.1%) |
| 2017 | -8.63(-16.6%) |
| 2016 | -10.35(-48.6%) |
| 2015 | -20.15(-5.2%) |
| 2014 | -21.25(+16.1%) |
| 2013 | -18.30(+659.3%) |
| 2012 | -2.41(-0.4%) |
| 2011 | -2.42(-65.1%) |
| 2010 | -6.93(-65.3%) |
| Date | Value |
|---|---|
| 2009 | -20.00(+1594.9%) |
| 2008 | -1.18(-87.0%) |
| 2007 | -9.07(+25.4%) |
| 2006 | -7.23(-58.0%) |
| 2005 | -17.23(+206.6%) |
| 2004 | -5.62(-38.0%) |
| 2003 | -9.07(+5235.3%) |
| 2002 | -0.17(-98.6%) |
| 2001 | -12.15(+3.9%) |
| 2000 | -11.69(-82.5%) |
| 1999 | -66.70(+275.4%) |
| 1998 | -17.77(+121.6%) |
| 1997 | -8.02(-69.9%) |
| 1996 | -26.63(+171.5%) |
| 1995 | -9.81(+77.7%) |
| 1994 | -5.52 |
FAQ
- What is BioCryst Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for BioCryst Pharmaceuticals?
- What is BCRX EV/EBITDA year-to-date change?
- What is BioCryst Pharmaceuticals EV/EBITDA year-on-year change?
What is BioCryst Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of BCRX is -99.80
What is the all time high EV/EBITDA for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high EV/EBITDA is 0.63
What is BCRX EV/EBITDA year-to-date change?
BioCryst Pharmaceuticals EV/EBITDA has changed by -6.87 (-7.39%) since the beginning of the year
What is BioCryst Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, BCRX EV/EBITDA has changed by -83.29 (-504.48%)